Hagar Nofal

Hagar Nofal

Auto-generated profile, based on publicly available information

Hagar Nofal

Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University , Egypt

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2021 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
HNHagar Nofal
Hagar Nofal
RARania AlAkad
Rania AlAkad
ANAhmad Nofal
Ahmad Nofal
EREman Rabie
Eman Rabie
TCThithiwat Chaikul
Thithiwat Chaikul
AOAlexandros Onoufriadis
Alexandros Onoufriadis

5 February 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
SISamia Ibrahim
Samia Ibrahim
AAAmin Amer
Amin Amer
HNHagar Nofal
Hagar Nofal
Ahmed AbdellatifAhmed Abdellatif
Ahmed Abdellatif
Psoriasis management is complex and challenging. It should be tailored for each patient. Treatment strategy differs according to patient's age, sex, disease type, disease severity, burden on patient's quality of life, comorbidities, involvement of specific sites, and pregnancy. The choice of the appropriate therapeutic must take into consideration the availability, the price and the patient's preferences. It is very important that the chosen treatment is not more unpleasant, intolerable or dangerous than the disease itself. According to the disease type, severity and effect on patient's quality of life, dermatologist chooses whether to start with topical therapy, phototherapy or systemic therapy or a combination of two or more of them. Under each category, there are different types of therapies that can be the first line therapeutics, second line or even contraindicated. In this compendium, we provide dermatologists with different treatment plans considering all the mentioned variables so that a dermatologist can choose the optimum plan for the patient.

1 January 2025 in Dermatologic Therapy
Verified
Journal Article
Open access
HNHagar Nofal
Hagar Nofal
AAAmin Amer
Amin Amer
NANourhan Anis
Nourhan Anis
RNRofida Nofal
Rofida Nofal
SNSara Nofal
Sara Nofal
DHDina Hamed
Dina Hamed
Methotrexate is a well‐known chemotherapeutic agent, widely used alone or in combination with other drugs in the treatment of cancer. Methotrexate applications in dermatology have significantly expanded over the years. Methotrexate is an established treatment modality for psoriasis; other indications include vitiligo, atopic dermatitis, immunobullous disorders, alopecia areata, neutrophilic dermatoses, and cutaneous T‐cell lymphoma. To increase the efficacy and reduce the potential adverse effects, different methotrexate forms and modes of delivery have been investigated including intralesional and topical modalities. Herein, dermatologists are introduced to methotrexate different indications in clinical practice, its mechanism of action, and the in‐depth knowledge needed to effectively and safely prescribe methotrexate to their patients with confidence. Mastery of prescribing methotrexate is an essential skill for dermatologists.

22 April 2025 in JAAD Reviews
Verified
Journal Article
Open access
HNHagar Nofal
Hagar Nofal
RARania AlAkad
Rania AlAkad
ANAhmad Nofal
Ahmad Nofal

18 December 2023 in Zagazig University Medical Journal
Verified
Journal Article
Closed access
ANAmany Nassar
Amany Nassar
RSReem K Soliman
Reem K Soliman
HNHagar Nofal
Hagar Nofal
Background: Melasma is a highly prevalent hyperpigmentation problem that affects a large percentage of the global population. It is most commonly seen in women and those with Fitzpatrick Skin Types III–VI. This hyperpigmentation condition has a complicated and multi-factorial pathophysiology. Intense exposure to ultra violet radiation, hormonal impacts, and hereditary susceptibility are the main contributors to the development of this illness. Melasma is classified as either epidermal or dermal, depending on the pattern of its pigmentation. Diagnosis of melasma is typically by clinical examination. Melasma Area and Severity Index (MASI) and modified MASI (mMASI) continue to be the most reliable melasma scoring methods. Melasma is difficult to treat because recurrences are common, and most patients do not have full lesion clearance. Conclusion: Current treatment of melasma includes the use of a combination of photoprotectants, skin lighteners (both oral and topical), and resurfacing techniques. Interventional therapies for melasma, both established and novel, are discussed in this article.

10 February 2021
Verified
Book Chapter
Open access
PDF file
AAAmin Amer
Amin Amer
MAMohamed Amer
Mohamed Amer
HNHagar Nofal
Hagar Nofal
Botulinum toxin is a corner stone in the facial esthetics. It has been used for decades for various medical and esthetic indications. Botulinum toxin is a neurotoxin that interferes with the transmission at the neuromuscular/neurosecretory junctions by inhibiting the release of acetylcholine. An in depth knowledge of the functional anatomy of facial muscles is required to obtain the best results of the botulinum toxin injections. In this book chapter, a detailed practical guide for the FDA approved and the off label uses of botulinum toxin in the face is presented. The recently developed new indications are listed. The lengthy experience with botulinum toxin injections has proved safety and tolerability of the procedure; however, the probable complications, and steps for their prevention and management are highlighted.